Nada Elbuluk, MD

Clinical Associate Professor of Dermatology (Clinician Educator)

Image of Nada Elbuluk, MD
Is this your profile? Click to edit


Dr. Nada Elbuluk is a board-certified dermatologist and Assistant Professor at the USC Keck School of Medicine, Department of Dermatology. She is honored to be a dermatologist at USC and to be able to serve the diverse population of Los Angeles. She is the founder and director of the USC Skin of Color Center and Pigmentary Disorders Clinic. She also serves as the Director of the Dermatology Diversity and Inclusion Program.

Dr. Elbuluk’s clinical and research interests include general medical and cosmetic dermatology,
ethnic skin conditions, and pigmentary disorders including vitiligo, melasma, and postinflammatory pigmentation. She performs a variety of procedures including chemical peels, microneedling, lasers, and botox and has expertise in safely performing these procedures in all skin types.

Dr. Elbuluk received her bachelor’s degree in Psychology from Princeton University where she also minored in Gender Studies and African American Studies. She completed her medical degree at the University of Michigan where she graduated with a Distinction in Research. While there, she received a National Institute of Health award that allowed her to also obtain a Master of Science in Clinical Research from the University of Michigan School of Public Health. She completed her dermatology residency at Johns Hopkins Hospital. Afterwards, she was a fellow and clinical instructor in the Dermatology Department at The University of Pennsylvania. She then spent four years as an Assistant Professor at New York University’s School of Medicine, where she was the founder and director of the pigmentary disorder clinic and served as the Diversity Ambassador for the Department.

Dr. Elbuluk feels strongly about providing her patients with the highest quality of individualized and compassionate care. She also is passionate about teaching and advancing the field of dermatology through research on pigmentary disorders and ethnic skin conditions. She has received several grants to support her research, which has been published in numerous academic journals. She has lectured both national and internationally on her areas of expertise. She also serves as a media expert for the American Academy of Dermatology and has been interviewed by numerous media outlets including the Washington Post, Health, Women’s Health, Essence, Prevention, Allure, Reader’s Digest, the Huffington Post, SELF, and

Dr. Elbuluk is a Diplomate of the American Academy of Dermatology and holds professional memberships with the American Academy of Dermatology, the Women’s Dermatologic Society, the American Society for Dermatologic Surgery, and the Skin of Color Society.


  • Cosmetic injectables in skin of color: A review of uses, safety, and effectiveness of neuromodulators and dermal fillers J Cosmet Dermatol. 2024 Mar 29. . View in PubMed
  • Integrating skin color assessments into clinical practice and research: A review of current approaches J Am Acad Dermatol. 2024 Feb 09. . View in PubMed
  • Best practices in the treatment of melasma with a focus on patients with skin of color J Am Acad Dermatol. 2024 Feb; 90(2):269-279. . View in PubMed
  • Cysteamine Isobionic-Amide Complex Versus Kligman’s Formula for the Treatment of Melasma: Equal Efficacy and Rapid Onset of Action J Drugs Dermatol. 2024 02 01; 23(2):9-16. . View in PubMed
  • Racial diversity in academic dermatology: A cross-sectional analysis of Black academic dermatology faculty in the United States J Am Acad Dermatol. 2024 Jan; 90(1):182-184. . View in PubMed
  • Psychological comorbidities of vitiligo: a retrospective cross-sectional analysis in an urban population Arch Dermatol Res. 2023 Dec 04; 316(1):14. . View in PubMed
  • Gaps in medical education curricula on skin of color in medical school, residency, and beyond: Part 1 J Am Acad Dermatol. 2023 Nov; 89(5):885-892. . View in PubMed
  • Racial and ethnic disparities in clinical research and the dermatology workforce: Part 2 J Am Acad Dermatol. 2023 Nov; 89(5):895-902. . View in PubMed
  • Targeting Inflammation in Acne: Current Treatments and Future Prospects Am J Clin Dermatol. 2023 Sep; 24(5):681-694. . View in PubMed
  • Disorders of Facial Hyperpigmentation Dermatol Clin. 2023 Jul; 41(3):393-405. . View in PubMed
  • Racial and Ethnic Disparities in Research and Clinical Trials Dermatol Clin. 2023 Apr; 41(2):351-358. . View in PubMed
  • Vitiligo and makeup: analyzing interest and usage trends in the 21st century Int J Dermatol. 2023 09; 62(9):e505-e506. . View in PubMed
  • Treatment recommendations for acne-associated hyperpigmentation: Results of the Delphi consensus process and a literature review J Am Acad Dermatol. 2023 08; 89(2):316-323. . View in PubMed
  • Clinical decision-making bias in darker skin types: a prospective survey study identifying diagnostic bias in decision to biopsy Int J Dermatol. 2023 04; 62(4):e252-e253. . View in PubMed
  • Rising Interest in Sunscreen for Skin of Color: An Analysis of Google Trends J Drugs Dermatol. 2023 07 01; 22(7):712-713. . View in PubMed
  • Radiofrequency and Radiofrequency Microneedling in Skin of Color: A Review of Usage, Safety, and Efficacy Dermatol Surg. 2023 05 01; 49(5):489-493. . View in PubMed
  • Pigmented Basal Cell Carcinoma: An Argument for Sub-Classification J Drugs Dermatol. 2023 02 01; 22(2):217-218. . View in PubMed
  • Postinflammatory hypopigmentation: a comprehensive review of treatments J Dermatolog Treat. 2022 Mar; 33(2):704-708. . View in PubMed
  • Variations in genetics, biology, and phenotype of cutaneous disorders in skin of colorPart II: Differences in clinical presentation and disparities in cutaneous disorders in skin of color. J Am Acad Dermatol. 2022 12; 87(6):1261-1270. . View in PubMed
  • Variations in genetics, biology, and phenotype of cutaneous disorders in skin of color – Part I: Genetic, biologic, and structural differences in skin of color J Am Acad Dermatol. 2022 12; 87(6):1239-1258. . View in PubMed
  • Skin Manifestations of Complex Regional Pain Syndrome Cutis. 2022 12; 110(6):E16-E18. . View in PubMed
  • Going Beyond Hydroquinone: Alternative Skin Lightening Agents Cutis. 2022 06; 109(6):302-304. . View in PubMed
  • Seborrheic macular hypopigmentation: a case series proposing a new pigmentary disorder J Eur Acad Dermatol Venereol. 2022 05; 36(5):e361-e362. . View in PubMed
  • Dermoscopy of acquired pigmentary disorders: a comprehensive review Int J Dermatol. 2022 Jan; 61(1):7-19. . View in PubMed
  • Telemedicine Alopecia Assessment: Highlighting Patients With Skin of Color Cutis. 2022 Jan; 109(1):40-42. . View in PubMed
  • The Pathogenesis and Management of Acne-Induced Post-inflammatory Hyperpigmentation Am J Clin Dermatol. 2021 Nov; 22(6):829-836. . View in PubMed
  • A quantitative analysis of research publications focused on the top chief complaints in patients with skin of color J Am Acad Dermatol. 2021 Jul; 85(1):241-242. . View in PubMed
  • A Multi-Centered Case-Control Study of Vitiligo Support Groups and Quality of Life J Drugs Dermatol. 2021 Jun 01; 20(6):672-675. . View in PubMed
  • Long term safety, tolerability, and efficacy of intracutaneous zolmitriptan (M207) in the acute treatment of migraine J Headache Pain. 2021 May 17; 22(1):37. . View in PubMed
  • A diverse nation calls for a diverse healthcare force EClinicalMedicine. 2021 Apr; 34:100846. . View in PubMed
  • Direct-to-consumer dermatology-related advertising differs in magazines targeted to women of color: A cross-sectional analysis of top-circulating consumer magazines Int J Womens Dermatol. 2021 Mar; 7(2):191-194. . View in PubMed
  • Vitiligo and Melanoma-Associated Vitiligo: Understanding Their Similarities and Differences Am J Clin Dermatol. 2020 Oct; 21(5):669-680. . View in PubMed
  • The Relevance of Vitamin D Supplementation for People of Color in the Era of COVID-19 J Drugs Dermatol. 2020 Jul 01; 19(7):782-783. . View in PubMed
  • Evaluating Population Interest in Vitiligo Through an Analysis of Google Trends and Social Media J Drugs Dermatol. 2020 Jun 01; 19(6):661-665. . View in PubMed
  • Comorbid diseases of vitiligo: A 10-year cross-sectional retrospective study of an urban US population J Am Acad Dermatol. 2020 Mar; 82(3):628-633. . View in PubMed
  • The digital divide: How COVID-19’s telemedicine expansion could exacerbate disparities J Am Acad Dermatol. 2020 11; 83(5):e345-e346. . View in PubMed
  • Why can we see our narrowband UVB lights? J Am Acad Dermatol. 2020 06; 82(6):e251-e252.. View in PubMed
  • Photolichenoid dermatitis: a presenting sign of human immunodeficiency virus Cutis. 2019 Oct; 104(4):242-244. . View in PubMed
  • Deficiency of sun protection advertising exists in consumer magazines across demographic groups and varies by target demographic J Am Acad Dermatol. 2019 Apr; 80(4):1139-1141. . View in PubMed
  • International Initiative for Outcomes (INFO) for vitiligo: workshops with patients with vitiligo on repigmentation Br J Dermatol. 2019 03; 180(3):574-579. . View in PubMed
  • Frontal fibrosing alopecia: cutaneous associations in women with skin of color Cutis. 2018 Nov; 102(5):335-338. . View in PubMed
  • Beyond Traditional Treatment: The Importance of Psychosocial Therapy in Vitiligo J Drugs Dermatol. 2018 Jun 01; 17(6):688-691. . View in PubMed
  • Disparity in Cutaneous Pigmentary Response to LED vs Halogen Incandescent Visible Light: Results from a Single Center, Investigational Clinical Trial Determining a Minimal Pigmentary Visible Light Dose J Drugs Dermatol. 2017 Nov 01; 16(11):1105-1110. . View in PubMed
  • Melasma: an Up-to-Date Comprehensive Review Dermatol Ther (Heidelb). 2017 Sep; 7(3):305-318. . View in PubMed
  • Quality of Life, Burden of Disease, Co-morbidities, and Systemic Effects in Vitiligo Patients Dermatol Clin. 2017 Apr; 35(2):117-128. . View in PubMed
  • A Difference in Cutaneous Pigmentary Response to LED Versus Halogen Incandescent Visible Light: A Case Report from a Single Center, Investigational Clinical Trial Determining a Minimal Pigmentary Visible Light Dose J Drugs Dermatol. 2017 Apr 01; 16(4):388-392. . View in PubMed
  • Microneedling: A Comprehensive Review Dermatol Surg. 2017 Mar; 43(3):321-339. . View in PubMed
  • The nuclear factor (erythroid-derived 2)-like 2 (NRF2) antioxidant response promotes melanocyte viability and reduces toxicity of the vitiligo-inducing phenol monobenzone Exp Dermatol. 2017 07; 26(7):637-644. . View in PubMed
  • Daily indoor light exposure: A spectral analysis of ambient light sources and its relevance to occupational dermatology J Am Acad Dermatol. 2017 04; 76(4):763-765. . View in PubMed
  • Advances in Vitiligo: An Update on Medical and Surgical Treatments J Clin Aesthet Dermatol. 2017 Jan; 10(1):15-28. . View in PubMed
  • Lichen planus pigmentosus and lichen planopilaris Dermatol Online J. 2016 Dec 15; 22(12). . View in PubMed
  • Lichen planus pigmentosus Dermatol Online J. 2016 Dec 15; 22(12). . View in PubMed
  • Common conditions in skin of color Semin Cutan Med Surg. 2016 Dec; 35(4):184-190. . View in PubMed
  • Infrared irradiation differentially alters collagen metabolism in lightly and darkly pigmented human skin in vivo J Dermatol Sci. 2016 Jun; 82(3):212-4. . View in PubMed
  • Microneedling in skin of color: A review of uses and efficacy J Am Acad Dermatol. 2016 Feb; 74(2):348-55. . View in PubMed
  • Cutaneous Rosai-Dorfman Disease in a Patient with Human Immunodeficiency Virus Dermatol Online J. 2016 Jan 15; 22(1). . View in PubMed
  • Recent advances in understanding vitiligo F1000Res. 2016; 5. . View in PubMed
  • Alternative Systemic Treatments for Vitiligo: A Review Am J Clin Dermatol. 2015 Dec; 16(6):463-74. . View in PubMed
  • Alteration in the gene encoding protein tyrosine phosphatase nonreceptor type 6 (PTPN6/SHP1) may contribute to neutrophilic dermatoses Am J Pathol. 2011 Apr; 178(4):1434-41. . View in PubMed
  • Cutis. 2011 Feb; 87(2):6576-7. . View in PubMed
  • Erythema nodosum leprosum, Sweet’s syndrome, and human immunodeficiency virus may be related through an overlap in immunopathogenesis Int J Dermatol. 2010 Nov; 49(11):1344-5. . View in PubMed
  • Retinoic acid 4-hydroxylase inducibility and clinical response to isotretinoin in patients with acne J Am Acad Dermatol. 2009 Aug; 61(2):252-8. . View in PubMed